Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10131667 Substituted tricyclic compounds as FGFR inhibitors

Patent 10131667 was granted and assigned to Incyte on November, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Incyte
Incyte
Date Filed
January 18, 2017
Date of Patent
November 20, 2018
Patent Application Number
15408768
Patent Citations Received
‌
US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same
‌
US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
0
‌
US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11466004 Solid forms of an FGFR inhibitor and processes for preparing the same
‌
US Patent 10450313 Bicyclic heterocycles as FGFR inhibitors
‌
US Patent 11530214 Bicyclic heterocycles as FGFR inhibitors
‌
US Patent 10611762 Crystalline forms of a FGFR inhibitor and processes for preparing the same
‌
US Patent 10632126 Bicyclic heterocycles as FGFR4 inhibitors
‌
US Patent 10738048 Bicyclic heterocycles as FGFR4 inhibitors
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10131667
Patent Primary Examiner
‌
Erich A Leeser

Find more entities like US Patent 10131667 Substituted tricyclic compounds as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo